Neurocrine halts development of schizophrenia drug as trial fails, ET HealthWorld
London: Neurocrine Biosciences said on Thursday it will halt the development of its experimental drug, aimed at improving cognitive function ...
London: Neurocrine Biosciences said on Thursday it will halt the development of its experimental drug, aimed at improving cognitive function ...
Wellness360 by Dr. Garg delivers the latest health news and wellness updates—curated from trusted global sources. We simplify medical research, trends, and breakthroughs so you can stay informed without the overwhelm. No clinics, no appointments—just reliable, doctor-reviewed health insights to guide your wellness journey